RenovoRx (RNXT) Accumulated Expenses (2020 - 2026)
RenovoRx (RNXT) posted Accumulated Expenses of $801000.0 for Q1 2026, down 31.13% sequentially from $1.2 million in Q4 2025, and up 4.16% YoY from $769000.0 in Q1 2025.
RenovoRx (RNXT) Accumulated Expenses (2020 - 2026) Analysis & Trends
RenovoRx has reported Accumulated Expenses for 7 years, with the latest figure at $801000.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 4.16% year-over-year to $801000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $801000.0 (up 4.16% YoY) and the FY2025 annual result came in at $1.2 million, down 12.09% from the prior year.
- Accumulated Expenses retreated to $801000.0 in Q1 2026 per RNXT's latest filing, from $1.2 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.3 million in Q4 2024 and troughed at $75000.0 in Q4 2023.
- A 5-year average of $579705.9 and a median of $477000.0 in 2023 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses tumbled 84.21% in 2023, then surged 1664.0% in 2024.
- Over 5 years, Accumulated Expenses stood at $475000.0 in 2022, then sank by 84.21% to $75000.0 in 2023, then soared by 1664.0% to $1.3 million in 2024, then dropped by 12.09% to $1.2 million in 2025, then tumbled by 31.13% to $801000.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $801000.0, $1.2 million, and $449000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | RenovoRx | 62.20 Mn | 62.20 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 801,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 449,000.00 |
| Jun 30, 2025 | 358,000.00 |
| Mar 31, 2025 | 769,000.00 |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 737,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 525,000.00 |
| Jun 30, 2023 | 322,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Dec 31, 2022 | 475,000.00 |
| Sep 30, 2022 | 269,000.00 |
| Jun 30, 2022 | 650,000.00 |
| Mar 31, 2022 | 154,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Sep 30, 2021 | 492,000.00 |